Investigating the Role of Impaired Mitochondrial Dynamics in Exfoliation Glaucoma
Principal Investigator
Arunkumar Venkatesan, PhD
SUNY Upstate Medical University
Syracuse, NY, United States
About the Research Project
Program
Award Type
Standard
Award Amount
$30,000
Active Dates
July 24, 2023 - June 23, 2024
Grant ID
CG2023001
Summary
Exfoliation glaucoma (XFG) is a more severe form of open angle glaucoma and a blinding disease. The eye starts accumulating white flaky fibrillar aggregates blocking fluid exit from the eye. As XFG is a multifactorial disease, evidence suggests that the pathogenesis of the disease is associated with genetic variants, environmental factors, protein aggregation, oxidative stress, and cellular dysfunction. This proposal aims to study defects in mitochondrial function in XFG patient-derived primary cells and the relationship of mitochondrial dysfunction to cellular senescence (aging cells). Mitochondria are essential cellular organelles that play critical roles in cellular energy metabolism and are known to be responsible for oxidative stress-induced damage in age-dependent neurodegenerations such as glaucoma. Hence, maintaining mitochondrial health is evolving as a fundamental part of preventing aging diseases. This study will evaluate how mitochondrial function is impaired in XFG and examine therapeutic strategies to enhance mitochondrial function for the treatment of XFG.
Related Grants
BrightFocus Foundation
lifespan perfusion TRAjectories In ageing and Alzheimer's Disease (TRAILAD)
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
James Cole, PhD
Current Organization
University College London (UCL)
lifespan perfusion TRAjectories In ageing and Alzheimer's Disease (TRAILAD)
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
James Cole, PhD
Current Organization
University College London (UCL)
BrightFocus Foundation
APP-mediated mechanical signaling and its regulation by Alzheimer’s risk genes
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Ben Goult, Ph.D.
Current Organization
University of Liverpool
APP-mediated mechanical signaling and its regulation by Alzheimer’s risk genes
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Ben Goult, Ph.D.
Current Organization
University of Liverpool
BrightFocus Foundation
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine